Considering the inaccessibility of BMD measurement in routine clinical practice, elevated circulating levels of adiponectin could serve as an alternate surrogate marker of low BMD and BF events in the CKD population with mineral dysregulation. This evidence concerns the gene ADIPOQ and chronic kidney disease.